200 related articles for article (PubMed ID: 26577653)
1. Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson's Disease.
Kelm-Nelson CA; Yang KM; Ciucci MR
J Parkinsons Dis; 2015; 5(4):749-63. PubMed ID: 26577653
[TBL] [Abstract][Full Text] [Related]
2. Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease.
Grant LM; Kelm-Nelson CA; Hilby BL; Blue KV; Paul Rajamanickam ES; Pultorak JD; Fleming SM; Ciucci MR
J Neurosci Res; 2015 Nov; 93(11):1713-27. PubMed ID: 26234713
[TBL] [Abstract][Full Text] [Related]
3. Intervention changes acoustic peak frequency and mesolimbic neurochemistry in the Pink1-/- rat model of Parkinson disease.
Stevenson SA; Ciucci MR; Kelm-Nelson CA
PLoS One; 2019; 14(8):e0220734. PubMed ID: 31374106
[TBL] [Abstract][Full Text] [Related]
4. Decreased approach behavior and nucleus accumbens immediate early gene expression in response to Parkinsonian ultrasonic vocalizations in rats.
Pultorak JD; Kelm-Nelson CA; Holt LR; Blue KV; Ciucci MR; Johnson AM
Soc Neurosci; 2016; 11(4):365-79. PubMed ID: 26313334
[TBL] [Abstract][Full Text] [Related]
5. Vocal and tongue exercise in early to mid-stage Parkinson disease using the Pink1-/- rat.
Hoffmeister JD; Broadfoot CK; Schaen-Heacock NE; Lechner SA; Krasko MN; Nisbet AF; Russell J; Szot J; Glass TJ; Connor NP; Kelm-Nelson CA; Ciucci MR
Brain Res; 2024 Aug; 1837():148958. PubMed ID: 38685371
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of vocal communication and anxiety through pharmacologic modulation of norepinephrine in the Pink1-/- rat model of Parkinson disease.
Hoffmeister JD; Kelm-Nelson CA; Ciucci MR
Behav Brain Res; 2022 Feb; 418():113642. PubMed ID: 34755639
[TBL] [Abstract][Full Text] [Related]
7. Gene expression within the periaqueductal gray is linked to vocal behavior and early-onset parkinsonism in Pink1 knockout rats.
Kelm-Nelson CA; Gammie S
BMC Genomics; 2020 Sep; 21(1):625. PubMed ID: 32942992
[TBL] [Abstract][Full Text] [Related]
8. Changes to Ventilation, Vocalization, and Thermal Nociception in the Pink1-/- Rat Model of Parkinson's Disease.
Johnson RA; Kelm-Nelson CA; Ciucci MR
J Parkinsons Dis; 2020; 10(2):489-504. PubMed ID: 32065805
[TBL] [Abstract][Full Text] [Related]
9. Early-onset Parkinsonian behaviors in female Pink1-/- rats.
Marquis JM; Lettenberger SE; Kelm-Nelson CA
Behav Brain Res; 2020 Jan; 377():112175. PubMed ID: 31542395
[TBL] [Abstract][Full Text] [Related]
10. Thyroarytenoid Muscle Gene Expression in a Rat Model of Early-Onset Parkinson's Disease.
Lechner SA; Kletzien H; Gammie SC; Kelm-Nelson CA
Laryngoscope; 2021 Dec; 131(12):E2874-E2879. PubMed ID: 34057223
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.
Kelm-Nelson CA; Trevino MA; Ciucci MR
Neuroscience; 2018 May; 379():126-141. PubMed ID: 29496635
[TBL] [Abstract][Full Text] [Related]
12. Targeted training of ultrasonic vocalizations in aged and Parkinsonian rats.
Johnson AM; Doll EJ; Grant LM; Ringel L; Shier JN; Ciucci MR
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847085
[TBL] [Abstract][Full Text] [Related]
13. Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease.
Grant LM; Richter F; Miller JE; White SA; Fox CM; Zhu C; Chesselet MF; Ciucci MR
Behav Neurosci; 2014 Apr; 128(2):110-21. PubMed ID: 24773432
[TBL] [Abstract][Full Text] [Related]
14. Vocal training, levodopa, and environment effects on ultrasonic vocalizations in a rat neurotoxin model of Parkinson disease.
Kelm-Nelson CA; Brauer AF; Ciucci MR
Behav Brain Res; 2016 Jul; 307():54-64. PubMed ID: 27025445
[TBL] [Abstract][Full Text] [Related]
15. Quantification of brainstem norepinephrine relative to vocal impairment and anxiety in the Pink1-/- rat model of Parkinson disease.
Hoffmeister JD; Kelm-Nelson CA; Ciucci MR
Behav Brain Res; 2021 Sep; 414():113514. PubMed ID: 34358571
[TBL] [Abstract][Full Text] [Related]
16. Atp13a2 expression in the periaqueductal gray is decreased in the Pink1 -/- rat model of Parkinson disease.
Kelm-Nelson CA; Stevenson SA; Ciucci MR
Neurosci Lett; 2016 May; 621():75-82. PubMed ID: 27057733
[TBL] [Abstract][Full Text] [Related]
17. Characterization of early-onset motor deficits in the Pink1-/- mouse model of Parkinson disease.
Kelm-Nelson CA; Brauer AFL; Barth KJ; Lake JM; Sinnen MLK; Stehula FJ; Muslu C; Marongiu R; Kaplitt MG; Ciucci MR
Brain Res; 2018 Feb; 1680():1-12. PubMed ID: 29229503
[TBL] [Abstract][Full Text] [Related]
18. Predictors of prodromal Parkinson's disease in young adult
Lechner SA; Welsch JM; Pahapill NK; Kaldenberg TAR; Regenbaum A; Kelm-Nelson CA
Front Behav Neurosci; 2022; 16():867958. PubMed ID: 36172466
[TBL] [Abstract][Full Text] [Related]
19. Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training.
Ciucci MR; Ma ST; Kane JR; Ahrens AM; Schallert T
Parkinsonism Relat Disord; 2008; 14 Suppl 2(Suppl 2):S172-5. PubMed ID: 18585950
[TBL] [Abstract][Full Text] [Related]
20. ParkinSong: A Controlled Trial of Singing-Based Therapy for Parkinson's Disease.
Tamplin J; Morris ME; Marigliani C; Baker FA; Vogel AP
Neurorehabil Neural Repair; 2019 Jun; 33(6):453-463. PubMed ID: 31081485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
